2006
DOI: 10.1074/jbc.r500021200
|View full text |Cite
|
Sign up to set email alerts
|

APOBEC3 Cytidine Deaminases: Distinct Antiviral Actions along the Retroviral Life Cycle

Abstract: The field of human immunodeficiency virus (HIV) biology has been galvanized by the discovery of innate APOBEC3 cytidine deaminases, which pose powerful barriers to the replication of HIV and other retroviruses. Rapid progress has been made in defining their action, intriguing regulation within cells, expanded range of retroviral targets, and counterstrikes utilized by retroviruses against them. Although scientifically fascinating, advances in APOBEC3 biology may lead to new antiviral drugs and improved lentivi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
37
0

Year Published

2006
2006
2010
2010

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 37 publications
(37 citation statements)
references
References 83 publications
0
37
0
Order By: Relevance
“…This interaction has raised therapeutic potentials, by either inhibiting Vif activity or boosting A3G levels above the neutralizing capacity of Vif to inhibit virus replication (5,26). The present studies have been confined to exploring the potential of up-regulating A3G expression first in vitro and then in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…This interaction has raised therapeutic potentials, by either inhibiting Vif activity or boosting A3G levels above the neutralizing capacity of Vif to inhibit virus replication (5,26). The present studies have been confined to exploring the potential of up-regulating A3G expression first in vitro and then in vivo.…”
Section: Discussionmentioning
confidence: 99%
“…A3G expression is enhanced in T cells by interleukin-2 (IL-2), IL-15, and, to a lesser extent, IL-7, as well as in DCs after exposure to a combination of tumor necrosis factor alpha (TNF-␣) and poly(I:C) (62). A3G is an innate barrier affording broad intracellular antiretroviral protection (15,16,58). The characterization of A3G has been carried out in T cells (17) or with recombinant A3G purified from insect cells (12), showing that the low-molecular-mass (LMM) complexes of A3G contain the antiretroviral activity.…”
mentioning
confidence: 99%
“…In the absence of Vif, A3G is recruited into budding virions through its interaction with the nucleocapsid component of the Gag polyprotein and/or HIV genomic RNA, as depicted in Figure 1A (number 1) and reviewed elsewhere [9][10][11]. These viruses are consequently rendered noninfectious because virion-encapsidated A3G undermines an integral subsequent step in the viral life cycle: reverse transcription.…”
Section: How A3g Exerts Its Antiviral Effectsmentioning
confidence: 97%
“…During reverse transcription, the RNA genome is first converted into a minus single-stranded DNA (ssDNA), which in turn serves as the template for the synthesis of a complementary plus (coding) strand to form a doublestranded DNA copy of the RNA genome. It is the minus ssDNA that A3G targets for deamination, converting deoxycytidines (dC) to deoxyuridines (dU) primarily at dCdC sites [9][10][11], with the frequency of mutation influenced by the duration of single strandedness [12••]. Although not fully understood, the presence of these dU residues may initiate nontemplate DNA repair by uracil DNA glycosylase [13] in an attempt to eliminate the unwanted uracil residues.…”
Section: How A3g Exerts Its Antiviral Effectsmentioning
confidence: 99%